Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from PACIFICA

Best beauty products of 2023 so far: From K18, Liz Earle, Isle of Paradise and more

Looking to purchase something in the world of new beauty? Well take a look at our guide for the best products that have launched this year - from fake tans to lipstick, hair devices, cleansers and so much more!

Daily Mirror

These are the EV models that will get you the full $7,500 tax credit

While President Biden is eager to accelerate the nation's rapid transition to electric vehicles, he'll only subsidize your EV purchase if you buy American. And the options right now are slim.

Los Angeles Times

North East deals of the week: key contracts, investments and acquisitions

Companies featuring in this week's round-up include Sustainable Business Services, Pacifica Group, Lockheed Martin and Port of Tyne

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Pacifica Group acquires South East-based appliance servicing firm Autowash

It is the latest in a string of purchases for the County Durham group

Birmingham Post

Deal helps save jobs at Liverpool white goods repair firm as it exits administration

The company's sales reached almost £1m during its most recent financial year

Liverpool Echo

Jobs saved after £1m white goods repairer JK Domestics acquired out of administration

The company has been bought by a nationwide competitor headquartered in the North East

Birmingham Post

Pacifica Group falls to a loss despite 'strength and agility' through pandemic

The Houghton-le-Spring group has this week announced its latest acquisition as it seeks to consolidate the appliance repair sector

Birmingham Post

Read news from The Economist, FT, and more,
with one subscription

CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval

The FDA approved CTI BioPharma Corp's (NASDAQ:CTIC) Vonjo (pacritinib) for treating adult patients with myelofibrosis, a type of bone marrow cancer with low blood platelets count. Pacritinib is a JAK inhibitor and will compete with Incyte Corporation's (NASDAQ:INCY) Jakafi and Bristol Myers Squibb's Co (NYSE:BMY) Inrebic, which were approved in 2011 and 2019, respectively for myelofibrosis. CTI…

Benzinga

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Northumbria University

82 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.